April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Widefield Megahertz (MHz) OCT of diabetic retinopathy
Author Affiliations & Notes
  • Jan Philip Kolb
    Institute for Biomolecular Optics, Faculty of Physics, Ludwig-Maximilians-University, Munich, Germany
  • Thomas Klein
    Institute for Biomolecular Optics, Faculty of Physics, Ludwig-Maximilians-University, Munich, Germany
  • Kathrin Mohler
    Institute for Biomolecular Optics, Faculty of Physics, Ludwig-Maximilians-University, Munich, Germany
  • Wolfgang Wieser
    Institute for Biomolecular Optics, Faculty of Physics, Ludwig-Maximilians-University, Munich, Germany
  • Lukas Reznicek
    Dept. of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
  • Marcus Kernt
    Dept. of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
  • Anselm Kampik
    Dept. of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
  • Aljoscha S Neubauer
    Dept. of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
  • Robert Huber
    Institute for Biomolecular Optics, Faculty of Physics, Ludwig-Maximilians-University, Munich, Germany
    Institute of Biomedical Optics, Universität zu Lübeck, Luebeck, Germany
  • Footnotes
    Commercial Relationships Jan Philip Kolb, None; Thomas Klein, None; Kathrin Mohler, None; Wolfgang Wieser, None; Lukas Reznicek, None; Marcus Kernt, None; Anselm Kampik, None; Aljoscha Neubauer, None; Robert Huber, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5018. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jan Philip Kolb, Thomas Klein, Kathrin Mohler, Wolfgang Wieser, Lukas Reznicek, Marcus Kernt, Anselm Kampik, Aljoscha S Neubauer, Robert Huber; Widefield Megahertz (MHz) OCT of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5018.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To investigate morphological appearance of diabetic retinopathy and laser effects in panretinal laser photocoagulation with a widefield MHz OCT (60° field of view, 120° center angle).

 
Methods
 

A custom swept-source OCT device with a 1060nm Fourier-domain mode-locked laser source achieving a line rate of 1.68MHz was used to investigate 15 consecutive patients with diabetic retinopathy. Within 1.82s datasets consisting of 2088x1024 A-scans over 60° were acquired. The densely sampled three dimensional datasets were investigated in various B-Scan cross-sections as well as en-face images and 3D reconstructions. Selected findings were compared with SLO images from a widefield SLO (Optos, Dunfermeline, UK).

 
Results
 

On the densely sampled 3D and en-face images, hard exsudates, peripheral laser spots as well as proliferative neovascularization were readily detected. Characteristic structural changes resulting from laser burns could easily be visualized across the whole field of view in the OCT datasets. In addition, depth-scans and B-scans allowed to identify additional structural changes including IS/OS disruption, RPE detachment or neovascularisation reaching into the vitreous across the field of view.

 
Conclusions
 

Three dimensional visualization of the retina over 60° field of view with a MHz OCT is feasible in patients with diabetic retinopathy. It might allow additional clinical insights in peripheral changes such as laser spots or retinal neovascularisation.

 
 
3D reconstruction of OCT dataset of patient with diabetic retinopathy with neovascularization (green), hard exsudates (yellow), epiretinal membrane and peripheral retinal scars after panretinal laser treatment (blue). Indications with arrows are examplatory.
 
3D reconstruction of OCT dataset of patient with diabetic retinopathy with neovascularization (green), hard exsudates (yellow), epiretinal membrane and peripheral retinal scars after panretinal laser treatment (blue). Indications with arrows are examplatory.
 
 
Top: En-face of same patient as in figure 1. Red line indicates the position of B-Frame below. Retinal scars due to focal laser coagulation temporal of the fovea visible. Bottom: Neovascularisation (green) reaching into the vitreous is visible on the left side. Retinal scars especially on RPE level due to panretinal laser treatment (blue) are observable.
 
Top: En-face of same patient as in figure 1. Red line indicates the position of B-Frame below. Retinal scars due to focal laser coagulation temporal of the fovea visible. Bottom: Neovascularisation (green) reaching into the vitreous is visible on the left side. Retinal scars especially on RPE level due to panretinal laser treatment (blue) are observable.
 
Keywords: 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • 578 laser • 499 diabetic retinopathy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×